. Author manuscript; available in PMC: 2015 Mar 1.

Published in final edited form as: Immunol Rev. 2014 Mar;258(1):12–29. doi: 10.1111/imr.12138

Table 4.

Outcome of treatment with third party VSTs in our studies

Specificity	Virus	Patients	Complete or partial response	Failure	References
Trivirus VSTs with prolonged culture
AD5/35pp65 induced CMV/AdV/EBV VSTs	EBV	9	6	3	Leen et al. 2013 (119)
	AdV	18	14	4
	CMV	23	17	6
TOTAL		50	37	13